ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

Could Coconut Oil Help Reduce Antibiotics?

 
Print Page
Email Article

Effect of adding milnacipran to pregabalin in the management of fibromyalgia: A randomized, open-label, controlled study – Source: Presentation at American Pain Society Annual Meeting, May 6-8 2010

  [ 58 votes ]   [ Discuss This Article ]
By Mildred Farmer, et al. • www.ProHealth.com • May 19, 2010


Clinical practice guidelines for treatment of fibromyalgia (FM) emphasize the role of pharmacologic interventions that address multiple symptoms, such as pain, fatigue, and sleep disturbance. Patients with FM may benefit from a combination of medications with complementary mechanisms of action that could yield additive or synergistic effects.

A rational combination therapy approach would be:

• Milnacipran [brand name Savella®], a dual reuptake inhibitor thought to augment norepinephrine and serotonin neurotransmitter signaling in descending pain modulatory neurons,

• Plus pregabalin [brand name Lyrica®), which may inhibit nociceptive signaling in ascending fibers through voltage-gated calcium channels.

This randomized, open-label, controlled study evaluated the efficacy and tolerability of milnacipran 50 mg BID when added to pregabalin 150 mg BID or 225 mg BID in FM patients who had an incomplete response to pregabalin during a 4- to 12-week open-label run-in phase.

Pregabalin incomplete responders (defined as patients with weekly recall VAS pain score 40 or more and 90 or less [0 to 100 scale], Patient Global Impression of Severity score 4 or more [moderately ill], and Patient Global Impression of Change [PGIC] score 3 or more [minimally improved]) were randomized to either pregabalin alone (n=179) or milnacipran with pregabalin (n=184) for 11 weeks.

The primary endpoint was an ITT responder analysis, with responders defined as patients reporting a PGIC score of “1” or “2” at endpoint.

• Significantly more patients receiving combination therapy were PGIC responders than patients receiving pregabalin alone.

• The addition of milnacipran to pregabalin also resulted in significantly greater reductions in mean weekly recall VAS pain scores.

• Approximately one-third of patients discontinued the study,

• With fewer patients discontinuing from the milnacipran with pregabalin combination group than pregabalin alone.

This was the first randomized controlled study to demonstrate that adding milnacipran to pregabalin therapy was tolerable and effective in improving global status and reducing pain in patients with FM. (Supported by Forest Laboratories, Inc. and Cypress Bioscience, Inc.)

Source: Presentation (Abstract #215) at American Pain Society Annual Meeting, May 6-8, 2010. By Farmer M, Dayani N, Trugman J, Wang Y, Gendreau R. Forest Research Institute and Cypress Bioscience, Inc., Jersey City, New Jersey and San Diego, California, USA.





Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Optimized Curcumin Longvida® Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients
The New Dual Activation Pain Relief Cream The New Dual Activation Pain Relief Cream
The Curcumin Revolution: 'Golden' Ticket to Better Health The Curcumin Revolution: 'Golden' Ticket to Better Health
The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol The Guaifenesin Story: A centuries-old bark extract used for clearing the airways – now key to a popular FM symptom-reversal protocol
A Hard-Working Molecule that May Help Ease Pain & Brighten Mood A Hard-Working Molecule that May Help Ease Pain & Brighten Mood

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map